The weekly litigation news digest is live. Subscribe now

IP Verse

Evive Biotechnology Shanghai competitive analysis

Loading summary...

Latest patents of Evive Biotechnology Shanghai opposed by its competitors

Explore Evive Biotechnology Shanghai's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 11, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3065763
Nov 1, 2023Use Of Il-22 Dimer In Manufacture Of A Medicament For Intravenous Administration1
EP3065777
Jul 12, 2023Methods Of Use For Il-22 In The Treatment Of Gastrointestinal Graft Vs. Host Disease1

Latest PTAB cases involving Evive Biotechnology Shanghai

Discover the latest PTAB cases involving Evive Biotechnology Shanghai, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Evive Biotechnology Shanghai with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 11, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
EVIVE BIOTECHNOLOGY SHANGHAI - 2 - -
STRAWMAN339 - - -